Organogenesis Holdings Inc (ORGO) — Cash Flow Quality Index
Organogenesis Holdings Inc (ORGO) has a Cash Flow Quality Index of 0.14x as of September 2025. Operating cash flow of $3.08 Million is below net income of $21.57 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ORGO debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Organogenesis Holdings Inc Cash Flow Quality Index (2020–2024)
Historical Cash Flow Quality Index for Organogenesis Holdings Inc across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Organogenesis Holdings Inc cash conversion from operations.
Annual Cash Flow Quality Index for Organogenesis Holdings Inc (2020–2024)
Year-by-year earnings quality comparison for Organogenesis Holdings Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 16.50x | $14.21 Million | $861.00K | ▲ +163.9% |
| 2023 | 6.25x | $30.92 Million | $4.95 Million | ▲ +290.6% |
| 2022 | 1.60x | $24.86 Million | $15.53 Million | ▲ +145.1% |
| 2021 | 0.65x | $61.98 Million | $94.90 Million | ▲ +105.9% |
| 2020 | 0.32x | $5.47 Million | $17.23 Million | — |